FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Summary

Drugs used in chemotherapy such as FR901228 use different ways to stop cancer cells from dividing so they stop growing or die. Phase II trial to study the effectiveness of FR901228 in treating patients who have relapsed or refractory multiple myeloma

Timeline

Start

2003-06

Primary completion

2007-05

Completion

2011-03

Drugs

Indications